Page last updated: 2024-09-03

vadimezan and evans blue

vadimezan has been researched along with evans blue in 1 studies

Compound Research Comparison

Studies
(vadimezan)
Trials
(vadimezan)
Recent Studies (post-2010)
(vadimezan)
Studies
(evans blue)
Trials
(evans blue)
Recent Studies (post-2010) (evans blue)
272161012,11912405

Protein Interaction Comparison

ProteinTaxonomyvadimezan (IC50)evans blue (IC50)
Luciferin 4-monooxygenasePhotinus pyralis (common eastern firefly)5.4
60 kDa heat shock protein, mitochondrialHomo sapiens (human)0.17
Tyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)1.3
Tyrosine-protein phosphatase 1Saccharomyces cerevisiae S288C1.2
10 kDa heat shock protein, mitochondrialHomo sapiens (human)0.17
Ectonucleotide pyrophosphatase/phosphodiesterase family member 2Homo sapiens (human)0.922
Thiosulfate sulfurtransferaseHomo sapiens (human)8.7
60 kDa chaperonin Escherichia coli0.063
10 kDa chaperonin Escherichia coli0.063

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baguley, BC; Ching, LM; Chung, F; Liu, J1

Other Studies

1 other study(ies) available for vadimezan and evans blue

ArticleYear
Consequences of increased vascular permeability induced by treatment of mice with 5,6-dimethylxanthenone-4-acetic acid (DMXAA) and thalidomide.
    Cancer chemotherapy and pharmacology, 2008, Volume: 61, Issue:3

    Topics: Animals; Antineoplastic Agents; Body Temperature; Capillary Permeability; Colonic Neoplasms; Coloring Agents; Drug Synergism; Evans Blue; Hematocrit; Liver Circulation; Mice; Mice, Inbred C57BL; Thalidomide; Xanthones

2008